Zhaoyu Huang, Zhiyong Zhai, Ping Zhou, Wanjun Li, Wei Hu and Wei Gong* Pages 1 - 20 ( 20 )
Antibiotic resistance has progressively diminished the effectiveness of conventional antibiotics, necessitating the cessation of clinical treatment. Consequently, novel antibacterial agents are urgently needed. We review studies on antimicrobial agents published during 2002-2023. Most of these studies were published within the last 10 years. By analyzing recent articles on antibiotic resistance and the development of new antibacterial drugs, we showed that although drug resistance is inevitable, the issue is being addressed gradually via the discovery and clinical application of antimicrobial peptides, nanomaterial drugs, and bacteriophage therapy. In light of the emergence of antimicrobial resistance, the development of new antimicrobial agents will require innovation in a field that has relied on traditional methods of discovery and development.
Antibiotics, antimicrobial agents, antimicrobial resistance, drug-resistant infections, antimicrobial peptides, bacteriophages, nanomaterial drugs.